↓ Skip to main content

Verification of EZH2 as a druggable target in metastatic uveal melanoma

Overview of attention for article published in Molecular Cancer, March 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Published in
Molecular Cancer, March 2020
DOI 10.1186/s12943-020-01173-x
Pubmed ID
Authors

Bei Jin, Ping Zhang, Hailin Zou, Huijing Ye, Yun Wang, Jing Zhang, Huasheng Yang, Jingxuan Pan

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 24%
Student > Ph. D. Student 4 12%
Student > Master 3 9%
Student > Doctoral Student 2 6%
Student > Postgraduate 2 6%
Other 2 6%
Unknown 12 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 24%
Medicine and Dentistry 7 21%
Agricultural and Biological Sciences 1 3%
Social Sciences 1 3%
Chemistry 1 3%
Other 0 0%
Unknown 15 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2020.
All research outputs
#13,659,944
of 23,573,357 outputs
Outputs from Molecular Cancer
#842
of 1,782 outputs
Outputs of similar age
#175,311
of 362,777 outputs
Outputs of similar age from Molecular Cancer
#18
of 41 outputs
Altmetric has tracked 23,573,357 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,782 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,777 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.